Pomerantz investigates Doximity after FY26 guidance misses estimates
Pomerantz LLP is investigating Doximity Inc. for potential securities fraud after the company's FY26 revenue guidance missed analyst estimates, causing a 23% stock drop. The investigation focuses on whether Doximity and its officers engaged in unlawful business practices. Management cited AI compute costs as a factor impacting gross margins and near-term profitability.
*this image is generated using AI for illustrative purposes only.
Pomerantz LLP is investigating claims on behalf of investors of Doximity Inc. regarding potential securities fraud and other unlawful business practices by the company and its officers. The investigation follows a sharp decline in Doximity's stock price after the company released its fourth quarter and fiscal year 2026 financial results. Investors are advised to contact the firm to discuss their legal options.
On May 13, 2026, Doximity issued a press release announcing its financial results. The company provided guidance for full-year revenue in the range of $664 million to $676 million, compared to estimates of $687.04 million. Additionally, Doximity guided for adjusted EBITDA of $323 million to $335 million.
Management highlighted AI cost pressures as a key factor affecting financial performance. The company's vice president of investor relations cited a gross margin impact "driven by AI compute costs." CEO Jeff Tangney warned that higher AI investment will "weigh on near-term margins."
Following this news, Doximity's stock price fell $5.38 per share, or 23%, to close at $18.01 per share on May 14, 2026. The significant drop in share price has prompted scrutiny from investors and legal analysts regarding the accuracy of prior disclosures and the company's forward-looking statements.
Financial Guidance vs Estimates
| Metric | Doximity Guidance | Analyst Estimates |
|---|---|---|
| Full-Year Revenue | $664 million - $676 million | $687.04 million |
| Adjusted EBITDA | $323 million - $335 million | Not Provided |
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is recognized as a premier firm in corporate, securities, and antitrust class litigation. The firm has recovered numerous multimillion-dollar damages awards on behalf of class members throughout its history.
How long does Doximity expect AI compute costs to pressure margins before efficiency improvements or pricing strategies offset the expenses?
Will the missed revenue targets and margin compression trigger a broader re-rating of growth stocks heavily investing in AI infrastructure?
What specific AI features or products is Doximity developing that justify the significant increase in compute costs?
15
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
